Curcumin Protects Nigrostriatal Dopaminergic Neurons and Reduces Glial Activation in 6-Hydroxydopamine Hemiparkinsonian Mice Model

REFERENCES

• DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13(7):281–5.
   PubMedGoogle Scholar
• Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybyłkowski A, Członkowski A, Członkowska A. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. Int Immunopharmacol. 2004;4(10-11):1307–18.
   PubMedGoogle Scholar
• McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988;24(4):574–6.
   PubMedGoogle Scholar
• Tripanichkul W, Sripanichkulchai K, Finkelstein DI. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication. Brain Res. 2006;1084(1):28–37.
   PubMedGoogle Scholar
• Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci. 2000;16(6):724–39.
   PubMedGoogle Scholar
• Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999;5(12):1403–9.
   PubMedGoogle Scholar
• Norenberg MD. Reactive astrocytosis. In: Michael Aschner and Harold K. Kimelberg (eds.). The role of glia in neurotoxicity. Boca Raton (FL): CRC Press; 1996. p. 93–107.
   Google Scholar
• Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem. 2002;83(4):973–83.
   PubMedGoogle Scholar
• Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2001;22(6):993–1005.
   PubMedGoogle Scholar
• Yang S, Zhang D, Yang Z, Hu X, Qian S, Liu J, Wilson B, Block M, Hong JS. Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res. 2008;33(10):2044–53.
   PubMedGoogle Scholar
• Rajeswari A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur Rev Med Pharmacol Sci. 2006;10(4): 157–61.
   PubMedGoogle Scholar
• Franklin KBJ, Paxinos G. The mouse brain in the stereotaxic coordinates. San Diego (CA): Academic Press; 1997.
   Google Scholar
• Gundersen HJ, Bagger P, Bendtsen TF, Evans, SM, Korbo, L, Marcussen, N, Møller, A, Nielsen, K, Nyengaard, JR, Pakkenberg, B, Sørensen, FB, Vesterby, A, West, MJ. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988;96(10):857–81.
   PubMedGoogle Scholar
• West MJ, Ostergaard K, Andreassen OA, Finsen, B. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol. 1996;370(1):11–22.
   PubMedGoogle Scholar
• Farkas E, Institoris A, Domoki F, Mihály, A, Luiten, PG, Bari, F. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 2004;1008(2):252–60.
   PubMedGoogle Scholar
• Zbarsky V, Datla KP, Parkar S, Rai, DK, Aruoma, OI, Dexter, DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005;39(10):1119–25.
   PubMedGoogle Scholar
• Xu Y, Ku BS, Yao HY, Lin, YH, Zhang, YH, L Xu. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005;518(1):40–6.
   PubMedGoogle Scholar
• Wang J, Du XX, Jiang H, Xie, JX. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol. 2009;78(2):178–83.
   PubMedGoogle Scholar
• Yu S, Zheng W, Xin N, Chi, ZH, Wang, NQ, Nie, YX, Feng, WY, Wang, ZY. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res. 2010;13(1):55–64.
   PubMedGoogle Scholar
• Gehrmann J, Schoen SW, Kreutzberg GW. Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study. Acta Neuropathol. 1991;82(6):442–55.
   PubMedGoogle Scholar
• Streit WJ, Kreutzberg GW. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol. 1988;268(2):248–63.
   PubMedGoogle Scholar
• Forno LS, DeLanney LE, Irwin I,Di Monte, D, Langston, JW. Astrocytes and Parkinson's disease. Prog Brain Res. 1992;94:429–36.
   PubMedGoogle Scholar
• He Y, Appel S, Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 2001;909(1–2):187–93.
   Google Scholar
• Wu DC, Jackson-Lewis V, Vila M, Tieu, K, Teismann, P, Vadseth, C, Choi, DK, Ischiropoulos, H, Przedborski, S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 2002;22(5):1763–71.
   PubMedGoogle Scholar
• Thanos S, Mey J, Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci. 1993;13(2):455–66.
   PubMedGoogle Scholar
• Tateishi N, Mori T, Kagamiishi Y, Satoh, S, Katsube, N, Morikawa, E, Morimoto, T, Matsui, T, Asano, T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. J Cereb Blood Flow Metab. 2002;22(6):723–34.
   PubMedGoogle Scholar
• Botchkina GI, Meistrell ME, 3rd, Botchkina IL, Tracey, KJ. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med. 1997;3(11):765–81.
   PubMedGoogle Scholar
• Ho A, Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J Neurosci. 1998;18(15):5614–29.
   PubMedGoogle Scholar
• Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Członkowski, A, Członkowska, A. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 1998;39(3):167–80.
   PubMedGoogle Scholar
• Lau LT, Yu AC. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma. 2001;18(3):351–9.
   PubMedGoogle Scholar
• Orzylowska O, Oderfeld-Nowak B, Zaremba M, Januszewski, S, Mossakowski, M. Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1beta and interleukin-6 in the rat hippocampus after transient global ischemia. Neurosci Lett. 1999;263(1):72–6.
   PubMedGoogle Scholar
• Schmidt B, Stoll G, Toyka KV, Hartung, HP. Rat astrocytes express interferon-gamma immunoreactivity in normal optic nerve and after nerve transection. Brain Res. 1990;515(1-2):347–50.
   PubMedGoogle Scholar
• Chao CC, Hu S, Molitor TW, Shaskan, EG, Peterson, PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol. 1992;149(8):2736–41.
   PubMedGoogle Scholar
• Colton CA, Keri JE, Chen WT, Monsky, WL. Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J Neurosci Res. 1993;35(3):297–304.
   PubMedGoogle Scholar
• Mollace V, Muscoli C, Rotiroti D, Nisticó, G. Spontaneous induction of nitric oxide- and prostaglandin E2-release by hypoxic astroglial cells is modulated by interleukin 1 beta. Biochem Biophys Res Commun. 1997;238(3):916–9.
   PubMedGoogle Scholar
• Piani D, Frei K, Do KQ, Cuénod, M, Fontana, A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett. 1991;133(2):159–62.
   PubMedGoogle Scholar
• Ambegaokar SS, Wu L, Alamshahi K, Lau, J, Jazayeri, L, Chan, S, Khanna, P, Hsieh, E, Timiras, PS. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuro Endocrinol Lett. 2003;24(6):469–73.
   PubMedGoogle Scholar
• Lin MS, Lee YH, Chiu WT, Hung, KS. Curcumin provides neuroprotection after spinal cord injury. J Surg Res. 2009;166(2):280–89.
   Google Scholar
• Zhang LJ, Wu CF, Meng XL, Yuan, D, Cai, XD, Wang, QL, Yang, JY. Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide. Neurosci Lett. 2008;447(1):48–53.
   PubMedGoogle Scholar